SO
ORIC icon

STRS Ohio’s Oric Pharmaceuticals ORIC Stock Holding History

STRS Ohio’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,400
Closed -$101K – 2058
2024
Q1 		$101K Sell
7,400
-500
-6% -$5.94K ﹤0.01% 1684
2023
Q4 		$72K Buy
+7,900
New +$57.1K ﹤0.01% 1733
2021
Q1 		– Sell
-5,400
Closed -$182K – 2251
2020
Q4 		$182K Buy
5,400
+3,200
+145% +$91.8K ﹤0.01% 1765
2020
Q3 		$55K Hold
2,200
– – ﹤0.01% 1952
2020
Q2 		$74K Buy
+2,200
New +$70.2K ﹤0.01% 1850

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return